GLYCANOVA AS

Keywords

productionpharmaceuticalsantiserablood fractionsvaccineshomeopathic preparationscontraceptive productsbone buildingdiagnostic preparationspregnancy testsbiotechnological medicinescotton woolgasbandagesdressings

Organization

CEO: BK
Bjørn Kristiansen1947
Chairman of the board: TP
Terje Pedersen1974
Years since formation: 15 years; since Apr 30, 2009
Type: Limited company
VAT registered: Yes
Number of employees: 0

Ownership

Number of shares and share classes: 388,413; 1 share class
Total number of shareholders: 77; 23 companies, 54 persons

Financials

Total operating income 2023: 1,008,875; NOK
Annual total result 2023: -2,909,702; NOK
Total equity 2023: -2,273,890; NOK

Last update: Aug 29, 2024

Management

Management / administration

Name	Role	Shares
BK Bjørn Kristiansen 1947	Managing Director/CEO	14.07 % directly

Board

Name	Role	Shares
BK Bjørn Kristiansen 1947	Board Member	14.07 % directly
TP Terje Pedersen 1974	Chairman	-
DB Dag Børge Hustad 1963	Board Member	1 % indirectly

Others

Name	Role	Shares
C CENTER REVISJON AS	Auditor	-
A AIDER AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
BK Bjørn Kristiansen 1947	Managing Director/CEO, Board Member	14.07 % directly
JK Joan Linden Kristiansen 1959	-	9.99 % directly
HT Hans Troye 1943	-	7.66 % directly
AH Anne Torill Hovland 1951	-	5.91 % directly
HØ Haakon Øystein Karlsen 1949	-	5.15 % directly
TP Terje Pedersen 1974	-	3.99 % indirectly
KT Kjell Trygve Torkildsen 1945	-	3.48 % directly
JA Jonathan James Aldwinckle 1975	-	3.33 % directly
JH Jørgen Gregardsøn Heje 1953	-	2.18 % indirectly
AJ Anne Josephine Walter Rutherford 1987	-	2.05 % indirectly

Last update: Feb 5, 2024

Ownership

Company shareholders

Name	Share class	Number of shares	Share
BK Bjørn Kristiansen 1947	Ordinary shares	54,645	14.07 %
JK Joan Linden Kristiansen 1959	Ordinary shares	38,800	9.99 %
HT Hans Troye 1943	Ordinary shares	29,744	7.66 %
W WALTER HOLDING AS	Ordinary shares	25,992	6.69 %
AH Anne Torill Hovland 1951	Ordinary shares	22,967	5.91 %
B BAKELITTFABRIKKEN HOLDING AS	Ordinary shares	22,499	5.79 %
HØ Haakon Øystein Karlsen 1949	Ordinary shares	20,000	5.15 %
T TIGERN INVEST AS	Ordinary shares	15,494	3.99 %
KT Kjell Trygve Torkildsen 1945	Ordinary shares	13,528	3.48 %
JA Jonathan James Aldwinckle 1975	Ordinary shares	12,938	3.33 %
F FREDRIKSTAD INNOVASJONSPARK AS	Ordinary shares	11,850	3.05 %
E EIDSIVA HOLDING AS	Ordinary shares	8,470	2.18 %
E EXAKT HOLDING AS	Ordinary shares	7,000	1.8 %
ER Enrique Rais	Ordinary shares	5,961	1.53 %
AØ Arne Johan Østenby 1956	Ordinary shares	5,888	1.52 %
EW Erik Wolff 1947	Ordinary shares	5,000	1.29 %
C CLC INVEST AS	Ordinary shares	4,397	1.13 %
AE Anne Elisabeth Lofterød 1945	Ordinary shares	4,000	1.03 %
H HUSTAD HOLDING AS	Ordinary shares	3,900	1 %
K KR7 HOLDING AS	Ordinary shares	3,300	0.85 %
U UNIMEDIC AS	Ordinary shares	3,168	0.82 %
D DBJ INVEST AS	Ordinary shares	3,070	0.79 %
C CLAYMORE AS	Ordinary shares	3,070	0.79 %
E EWR HOLDING AS	Ordinary shares	3,070	0.79 %
DH Daniel Jachowski Henriksen 1979	Ordinary shares	3,000	0.77 %
G GRAM INTERNATIONAL INC	Ordinary shares	2,950	0.76 %
SM Schiller Magnus	Ordinary shares	2,787	0.72 %
JK Jane Kristiansen 1975	Ordinary shares	2,761	0.71 %
P PFT HOLDING AS	Ordinary shares	2,650	0.68 %
AR Amen Ron	Ordinary shares	2,500	0.64 %
J JOMA INVEST AS	Ordinary shares	2,250	0.58 %
AD Andre Didriksen 1969	Ordinary shares	2,034	0.52 %
AM Ann Karene Molvig 1976	Ordinary shares	2,000	0.51 %
DA Danielsen Hanquet Angelique	Ordinary shares	2,000	0.51 %
RH Rolf Holten 1943	Ordinary shares	2,000	0.51 %
PB Per Trygve Berg 1937	Ordinary shares	2,000	0.51 %
LL Lars Christian Ly 1944	Ordinary shares	2,000	0.51 %
H H.P. FINNE AS	Ordinary shares	1,935	0.5 %
LS Lisa Suet Kei Ip 1978	Ordinary shares	1,600	0.41 %
SA Svein Arne Sunde 1968	Ordinary shares	1,546	0.4 %
JR Jan Roar Orlin 1942	Ordinary shares	1,546	0.4 %
M MARIADASAN AS	Ordinary shares	1,538	0.4 %
AB Andreas Benois De Brucq 1979	Ordinary shares	1,500	0.39 %
RA Ronny Andersen 1971	Ordinary shares	1,500	0.39 %
EK Espen Kjølberg 1972	Ordinary shares	1,340	0.34 %
JO Johan Orlin 1969	Ordinary shares	1,252	0.32 %
SM Steinar Mellingen 1949	Ordinary shares	1,212	0.31 %
CA Constable Adam	Ordinary shares	1,167	0.3 %
SC Smelt Christopher	Ordinary shares	1,064	0.27 %
CB Christopher Billington 1974	Ordinary shares	1,000	0.26 %
QA Quinlan Anne	Ordinary shares	829	0.21 %
LK Lewis Linden Kristiansen 1986	Ordinary shares	800	0.21 %
JR Jan Robert Danielsen 1950	Ordinary shares	769	0.2 %
EN Erik Norgaard 1956	Ordinary shares	706	0.18 %
BT Bjørn Thorsen 1962	Ordinary shares	684	0.18 %
WM Wakefield Thompson Mark	Ordinary shares	680	0.18 %
HS Håkon Sandmark 1974	Ordinary shares	525	0.14 %
HM Henrik Myhre-Sandmark 1980	Ordinary shares	525	0.14 %
TW Terje Gustav Waal 1953	Ordinary shares	500	0.13 %
G G LUND INVEST AS	Ordinary shares	460	0.12 %
T TUVERUD AS	Ordinary shares	460	0.12 %
BC Baker Carol	Ordinary shares	447	0.12 %
CM Corinna Maintz 1969	Ordinary shares	439	0.11 %
LD Ludger Dorlöchter 1967	Ordinary shares	439	0.11 %
KF Knut Frederik Horn 1945	Ordinary shares	400	0.1 %
E ENM INVEST AS	Ordinary shares	294	0.08 %
KS Knight Stuart	Ordinary shares	250	0.06 %
LT Leif-Ivan Thomassen 1996	Ordinary shares	200	0.05 %
B BLUE PROTEIN AS	Ordinary shares	200	0.05 %
SA Svein Arne Vabø 1966	Ordinary shares	150	0.04 %
AB Andreas Berntsen 1981	Ordinary shares	150	0.04 %
TA Tomas Alnæs 1985	Ordinary shares	150	0.04 %
WK William Karlsen 1982	Ordinary shares	139	0.04 %
IL Inger Lill Erichsen Pedersen 1953	Ordinary shares	100	0.03 %
KB Kari Bjørk 1953	Ordinary shares	100	0.03 %
CT Crighton Tim	Ordinary shares	84	0.02 %
M MOLDBAKKEN AS	Ordinary shares	50	< 0.01 %

Last update: May 24, 2024

Financials

in NOK

Summary

Year	2023	2022	2021
Total operating income	1,008,875	2,573,485	2,199,561
Annual Total Result	-2,909,702	-3,897,706	-2,834,922
Total assets	618,556	1,613,619	4,420,127
Total liabilities	2,892,446	1,985,306	894,109
Total equity	-2,273,890	-371,688	3,526,018

P&L

Year	2023	2022	2021
Total operating income	1,008,875	2,573,485	2,199,561
Total operating costs	3,932,112	6,450,780	4,964,232
Operating result	-2,923,236	-3,877,296	-2,764,671
Financial income/costs	13,534	-20,410	-70,251
Profit before tax	-2,909,702	-3,897,706	-2,834,922
Total tax & extraordinary income/cost	0	0	0
Annual Total Result	-2,909,702	-3,897,706	-2,834,922

Balance overview

Year	2023	2022	2021
Total fixed assets	184,236	351,331	715,226
Total current assets	434,320	1,262,288	3,704,901
Total assets	618,556	1,613,619	4,420,127
Short term debt	2,892,446	1,985,306	894,109
Long term debt	0	0	0
Total liabilities	2,892,446	1,985,306	894,109
Contributed capital	14,578,955	13,571,455	13,571,455
Retained earnings	-16,852,845	-13,943,143	-10,045,437
Total equity	-2,273,890	-371,688	3,526,018
Total equity and liabilities	618,556	1,613,619	4,420,127

GLYCANOVA AS994 035 495

GLYCANOVA AS

Keywords

Organization

Ownership

Financials

Management

Management / administration

Board

Others

Top 10 individual shareholders

Ownership

Company shareholders

Financials

Summary

P&L

Balance overview

Classification